- Home
- / CSPC Pharmaceutical Group
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
CSPC Pharmaceutical Group financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$6.2
2024-10-29
Market Capitalization
$70.4 B
2024-10-29
Revenue
¥26 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.7B | 22.1B | 24.9B | 27.9B | 30.9B | 31.5B | 29.0B | 26.0B |
| Cost of goods sold | 5.4B | 5.5B | 5.4B | 5.9B | 7.6B | 8.2B | 7.4B | 7.5B |
| Gross profit | 12.4B | 16.8B | 19.7B | 22.2B | 23.7B | 23.6B | 22.0B | 19.0B |
| Gross profit margin, % | 75.9% | 78.8% | 79.8% | 74.9% | 75.7% | 73.2% | ||
| Operating expense total | 8.2B | 11.6B | 13.3B | 14.9B | 15.5B | 15.3B | 15.0B | 13.2B |
| Depreciation and amortization | 614.1M | 691.6M | 808.8M | 915.5M | 1.1B | 1.2B | 1.3B | 1.4B |
| EBITDA | 4.3B | 5.2B | 6.4B | 7.3B | 8.2B | 8.2B | 6.8B | 5.8B |
| EBITDA margin, % | 23.7% | 25.7% | 26.2% | 26.2% | 23.6% | 22.3% | ||
| EBIT | 3.8B | 4.6B | 5.9B | 6.5B | 7.2B | 7.1B | 5.4B | 4.7B |
| EBIT margin, % | 20.7% | 23.8% | 23.3% | 22.4% | 18.6% | 18.0% | ||
| Interest income | 53.1M | 64.7M | 102.8M | 183.2M | 242.5M | 259.9M | 232.5M | 195.9M |
| Interest expense | 74.3M | 32.4M | 12.2M | 7.7M | 24.9M | 25.9M | 43.7M | 38.6M |
| Pre tax profit | 3.8B | 4.6B | 6.4B | 6.8B | 7.6B | 7.4B | 5.6B | 4.8B |
| Income tax expense | 733.8M | 892.8M | 1.2B | 1.2B | 1.4B | 1.3B | 1.2B | 931.7M |
| Net Income | 3.1B | 3.7B | 5.2B | 5.7B | 6.2B | 6.1B | 4.3B | 3.9B |